• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 24th May 2019

OHE is Leading Research to Develop EQ-5D ‘Bolt-ons’ for Cognition and Vision

In collaboration with University of Technology Sydney, we’re leading a study funded by the EuroQol Research Foundation to develop ‘bolt-on’ descriptors for the EQ-5D. The goal is to develop and test new questions that can be used with people who…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

In collaboration with University of Technology Sydney, we’re leading a study funded by the EuroQol Research Foundation to develop ‘bolt-on’ descriptors for the EQ-5D. The goal is to develop and test new questions that can be used with people who have cognitive impairment or visual impairment.

OHE and the University of Technology Sydney are leading a study funded by the EuroQol Research Foundation to develop ‘bolt-on’ descriptors for the EQ-5D. The goal is to develop and test new questions that can be used with people who have cognitive impairment or visual impairment. We’re currently seeking research participants.

The EQ-5D descriptive system forms the basis of a questionnaire that is widely used in health research. In particular, the EQ-5D is used to estimate quality-adjusted life years (QALYs), which are the cornerstone of value in health technology assessment in the UK and elsewhere. However, in certain circumstances, the EQ-5D has been shown to perform less well than other measures of health outcome. In particular, the EQ-5D sometimes does not detect meaningful changes in cognitive function and visual function. This has led some researchers to call for the development of ‘bolt-on’ items, which would be additional aspects of health added to the core set of five EQ-5D domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). The EuroQol Group is keen to explore the development of bolt-ons, though it is not committed to expanding the EQ-5D at this stage.

In collaboration with the University of Technology Sydney, the University of Central Lancashire, and the University of Nottingham, we have been funded by the EuroQol Research Foundation to develop bolt-on descriptors for cognition and vision. Researchers are increasingly recognising the need for health outcome measurement to be patient-centred, which means that the development of new measures should be informed by the views of people who will ultimately be asked to complete the questionnaires. To this end, our work will employ both qualitative and quantitative research methods to develop candidate bolt-ons. The project is organised into three phases.

Phase 1: Development of descriptors

In the first part of the study, we will generate a set of possible descriptors that might make for suitable bolt-on items. To do this, we’re conducting literature reviews and focus groups. By reviewing health status measures that are currently used in the context of cognitive impairment and visual impairment, we can understand how the impact of cognition and vision problems is currently captured. We can also identify the various terminologies that are used in questionnaires. The groundwork of the literature review will guide a set of focus groups, which we will be conducting in the UK. Participants will have varying degrees of impairment and will be asked to discuss the ways in which cognitive or visual impairment affects their quality of life, and how they would describe that.

Phase 2: Qualitative testing

Based on the findings from Phase 1, we’ll carry out a series of interviews with people who have experience of cognitive impairment or visual impairment. We’ll ask participants to complete EQ-5D-5L questionnaires with candidate bolt-on descriptors, followed by cognitive debriefing. This will help us to understand potential difficulties with comprehensibility or accessibility.

Phase 3: Quantitative testing

Once we have a set of possible bolt-on descriptors, they will be subject to psychometric testing. This will involve a cross-sectional survey conducted online and by telephone, which will ask participants to complete the EQ-5D-5L questionnaire with candidate bolt-on items, as well as other condition-specific instruments. The testing will include classical psychometrics and regression, factor analysis, and Rasch analysis.

Get involved

We are currently conducting Phase 1 of the study and we are looking for participants to take part in focus groups and interviews. If you have experienced cognitive impairment or visual impairment, or you are a caregiver for somebody who has, please consider volunteering your time to our research.

If you are a researcher, you can follow the progress of our project on ResearchGate.

For more information about the study, or to express an interest in taking part, please contact Chris Sampson.

 

Related research

Devlin, N.J. and Brooks, R., 2017. EQ-5D and the EuroQol Group: Past, Present and Future. Applied Health Economics and Health Policy, 15(2), pp.127–137. DOI. RePEc.

Shah, K.K., Mulhern, B., Longworth, L. and Janssen, M.F., 2017. Views of the UK General Public on Important Aspects of Health Not Captured by EQ-5D. The Patient, 10(6), pp.701–709. DOI. RePEc.

Cubí-Mollá, P., de Vries, J. and Devlin, N., 2014. A Study of the Relationship between Health and Subjective Well-Being in Parkinson’s Disease Patients. Value in Health, 17(4), pp.372–379. DOI. RePEc.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Grants

Related News

  • News
  • December 2019

New OHE Research Funding: Improving Labour Productivity in Primary Care

Read more
  • News
  • October 2019

Making Outcome-based Payment a Reality in the NHS: Moving to the Next Phase

Read more
  • News
  • September 2018

UKRI Funds OHE Collaboration in Student Mental Health Research Network

Read more
  • News
  • August 2018

OHE Awarded Research Grant to Evaluate PSS CQUIN Interventions

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!